Prestige Biologics Co. Ltd.

KQ:334970 Korea Pharmaceuticals

Market Cap

$15.55K

₩22.77 Million KRW

Market Cap Rank

#22903 Global

#1200 in Korea

Share Price

₩2530.00

Change (1 day)

-2.50%

52-Week Range

₩2400.00 - ₩4840.00

All Time High

₩19250.00

Prestige Biologics Co. Ltd. - Asset Resilience Ratio

Latest as of March 2023: 15.85%

Prestige Biologics Co. Ltd. (334970) has an Asset Resilience Ratio of 15.85% as of March 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₩50.57 Billion

Cash + Short-term Investments

Total Assets

₩319.05 Billion

All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2018–2022)

This chart shows how Prestige Biologics Co. Ltd.'s Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Prestige Biologics Co. Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩50.57 Billion	15.85%
Short-term Investments	₩0.00	0%
Total Liquid Assets	₩50.57 Billion	15.85%

Asset Resilience Insights

Good Liquidity Position: Prestige Biologics Co. Ltd. maintains a healthy 15.85% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.